메뉴 건너뛰기




Volumn 48, Issue 5, 2007, Pages 881-884

A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft

Author keywords

Autologous stem cell transplantation; Hodgkin's lymphoma; Relapse

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PROCARBAZINE; THIOTEPA; VINBLASTINE; VINCRISTINE;

EID: 34547423172     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701216394     Document Type: Article
Times cited : (12)

References (16)
  • 1
    • 0033650534 scopus 로고    scopus 로고
    • Autologous hematopoietic cell transplantation in Hodgkin's disease
    • Johnston, L. J. and Horning, S. J. (2000) Autologous hematopoietic cell transplantation in Hodgkin's disease. Biol Blood Marrow Transplant, 6, pp. 289-300.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 289-300
    • Johnston, L.J.1    Horning, S.J.2
  • 2
    • 0038182732 scopus 로고    scopus 로고
    • High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: A multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence
    • Tarella, C., Cuttica, A., Vitolo, U., Liberati, M., Nicola, M Di and Cortelazzo, S. (2003) High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: A multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence. Cancer, 97, pp. 2748-2759.
    • (2003) Cancer , vol.97 , pp. 2748-2759
    • Tarella, C.1    Cuttica, A.2    Vitolo, U.3    Liberati, M.4    Nicola, M.5    Di Cortelazzo, S.6
  • 3
    • 0027404777 scopus 로고
    • Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
    • Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B. and McMillan, A. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet, 341, pp. 1051-1054.
    • (1993) Lancet , vol.341 , pp. 1051-1054
    • Linch, D.C.1    Winfield, D.2    Goldstone, A.H.3    Moir, D.4    Hancock, B.5    McMillan, A.6
  • 4
    • 0037097044 scopus 로고    scopus 로고
    • Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial
    • Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A. M. and Haenel, M. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet, 359, pp. 2065-2071.
    • (2002) Lancet , vol.359 , pp. 2065-2071
    • Schmitz, N.1    Pfistner, B.2    Sextro, M.3    Sieber, M.4    Carella, A.M.5    Haenel, M.6
  • 5
    • 0026788310 scopus 로고
    • Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up
    • Vose, J. M., Bierman, P. J., Anderson, J. R., Kessinger, A., Pierson, J. and Nelson, J. (1992) Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up. Blood, 80, pp. 2142-2148.
    • (1992) Blood , vol.80 , pp. 2142-2148
    • Vose, J.M.1    Bierman, P.J.2    Anderson, J.R.3    Kessinger, A.4    Pierson, J.5    Nelson, J.6
  • 6
    • 0033745817 scopus 로고    scopus 로고
    • Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
    • Shamash, J., Lee, S. M., Radford, J. A., Rohatiner, A. Z., Chang, J. and Morgenstern, G. R. (2000) Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study. Ann Oncol, 11, pp. 715-719.
    • (2000) Ann Oncol , vol.11 , pp. 715-719
    • Shamash, J.1    Lee, S.M.2    Radford, J.A.3    Rohatiner, A.Z.4    Chang, J.5    Morgenstern, G.R.6
  • 7
    • 0033932803 scopus 로고    scopus 로고
    • Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study
    • Santoro, A., Bredenfeld, H., Devizzi, L., Tesch, H., Bonfante, V. and Viviani, S. (2000) Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study. J Clin Oncol, 18, pp. 2615-2619.
    • (2000) J Clin Oncol , vol.18 , pp. 2615-2619
    • Santoro, A.1    Bredenfeld, H.2    Devizzi, L.3    Tesch, H.4    Bonfante, V.5    Viviani, S.6
  • 8
    • 0027483826 scopus 로고
    • Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience
    • Anderson, J. E., Litzow, M. R., Appelbaum, F. R., Schoch, G., Fisher, L. D. and Buckner, C. D. (1993) Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience. J Clin Oncol, 11, pp. 2342-2350.
    • (1993) J Clin Oncol , vol.11 , pp. 2342-2350
    • Anderson, J.E.1    Litzow, M.R.2    Appelbaum, F.R.3    Schoch, G.4    Fisher, L.D.5    Buckner, C.D.6
  • 10
    • 0030008082 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease
    • Milpied, N., Fielding, A. K., Pearce, R. M., Ernst, P. and Goldstone, A. H. (1996) Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. J Clin Oncol, 14, pp. 1291-1296.
    • (1996) J Clin Oncol , vol.14 , pp. 1291-1296
    • Milpied, N.1    Fielding, A.K.2    Pearce, R.M.3    Ernst, P.4    Goldstone, A.H.5
  • 11
    • 20444410110 scopus 로고    scopus 로고
    • Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
    • Peggs, K. S., Hunter, A., Chopra, R., Parker, A., Mahendra, P. and Milligan, D. (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet, 365, pp. 1934-1941.
    • (2005) Lancet , vol.365 , pp. 1934-1941
    • Peggs, K.S.1    Hunter, A.2    Chopra, R.3    Parker, A.4    Mahendra, P.5    Milligan, D.6
  • 12
    • 0027770691 scopus 로고
    • Second autologous bone marrow transplantation in Hodgkin's disease
    • Avalos, B. R. and Copelan, E. A. (1993) Second autologous bone marrow transplantation in Hodgkin's disease. Bone Marrow Transplant, 12, pp. 665-667.
    • (1993) Bone Marrow Transplant , vol.12 , pp. 665-667
    • Avalos, B.R.1    Copelan, E.A.2
  • 14
    • 0030949743 scopus 로고    scopus 로고
    • Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry
    • Vandenberghe, E., Pearce, R., Taghipour, G., Fouillard, L. and Goldstone, A. H. (1997) Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry. J Clin Oncol, 15, pp. 1595-1600.
    • (1997) J Clin Oncol , vol.15 , pp. 1595-1600
    • Vandenberghe, E.1    Pearce, R.2    Taghipour, G.3    Fouillard, L.4    Goldstone, A.H.5
  • 15
    • 0036467658 scopus 로고    scopus 로고
    • Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial
    • Horning, S. J., Hoppe, R. T., Breslin, S., Bartlett, N. L., Brown, B. W. and Rosenberg, S. A. (2002) Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol, 20, pp. 630-637.
    • (2002) J Clin Oncol , vol.20 , pp. 630-637
    • Horning, S.J.1    Hoppe, R.T.2    Breslin, S.3    Bartlett, N.L.4    Brown, B.W.5    Rosenberg, S.A.6
  • 16
    • 33751531237 scopus 로고    scopus 로고
    • Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?
    • Diehl, V. and Behringer, K. (2000) Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?. Cancer Invest, 24, pp. 713-717.
    • (2000) Cancer Invest , vol.24 , pp. 713-717
    • Diehl, V.1    Behringer, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.